Concepedia

Lawrence A. Reiter

LA

Statistics

Publications

29

Citations

1.2K

H-Index

21

Active since

1982

Affiliations

Pfizer (United States)(Current)

Massachusetts Institute of Technology

Lawrence A. Reiter is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1982–2021

29

Publications

29

Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666

Kenneth W. Duncan, Nathalie Rioux, P. Ann Boriack‐Sjodin et al. · ACS Medicinal Chemistry Letters · 2015 · 151 citations · Full text

, , +15

Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation

Erin Matthews, Damien Thévenin, Julia M. Rogers et al. · The FASEB Journal · 2011 · 80 citations · Full text

, , +17

Discovery of the Hemifumarate and (α-<scp>l</scp>-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole:  Prodrugs for the Enolic OH Group

Ralph P. Robinson, Lawrence A. Reiter, Wayne E. Barth et al. · Journal of Medicinal Chemistry · 1996 · 75 citations

, , +9

Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14

Julian Blagg, Mark C. Noe, Lilli A. Wolf‐Gouveia et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 59 citations · Full text

, , +13

Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1

Lawrence A. Reiter, Ralph P. Robinson, Kim F. McClure et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 57 citations · Full text

, , +5

1–5 of 29